CXCL2 and chronic obstructive pulmonary disease: We found that the elastase-induced increase in the levels of IL-1β and CXCL2, which are cytokines related to COPD progression and inflammatory processes, were ameliorated in all of the treatment groups, including the BGF treatment group (Fig. 1E).